MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

MDS Virtual Congress 2020

September 12-16, 2020. Virtual Congress. www.mdscongress.org

View by Title View Categories
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z
  • The First-Ever CNV Analysis in Latin American Parkinson’s Disease Patients

    E.I Sarihan, E. Pérez-Palma, L.M Niestroj, D. Loesch, M. Seyfi, M. Inca-Martinez, A. Horimoto, M. Cornejo-Olivas, L. Torres, P. Mazzetti, C. Cosentino, E. Dieguez, V. Raggio, A. Lescano, V. Tumas, V. Borges, H.B Ferraz, C. Rieder, A. Schumacher-Schuh, B.L Santos-Lobato, C. Velez-Pardo, M. Jimenez-Del-Rio, F. Lopera, P. Chana-Cuevas, W. Fernandez, G. Arboleda, H. Arboleda, C.E Arboleda-Bustos, D. Yearout, C.P Zabetian, T. Thornton, T.D O’Connor, D. Lal, I.F Mata (Cleveland, OH, USA)

  • The Fragile X Mental Retardation Protein is lost prior to the appearance of Lewy pathology in Parkinson’s disease

    T. Koeglsperger, Y. Tan, C. Sgobio, T. Arzberger, F. Machleid, Q. Tang, E. Findeiss, J. Tost, T. Chakroun, P. Gao, M. Höllerhage, K. Bötzel, J. Herms, G. Höglinger (Evry Cedex, France)

  • The Future of Hospitalization for People with Parkinson’s Disease

    A. Wallis, D. Perret (Miami, FL, USA)

  • The genetic study of autosomal dominant spinocerebellar ataxia in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, J. Jarmukhanov, V. Akhmetzhanov, A. Taskynbayeva, C. Shashkin (Shymkent, Kazakhstan)

  • The genetic study of hereditary chorea in Kazakhstan

    R. Kaiyrzhanov, N. Zharkinbekova, A. Aitkulova, V. Akhmetzhanov, Z. Jarmukhanov, H. Houlden (London, United Kingdom)

  • The Gut Dysmotility Questionnaire (GDQ) for Parkinson’s disease: current development

    V. Räder, K.R Chaudhuri, L. Batzu, V. Leta, H. Reichmann, B. Falkenburger, L. Klingelhoefer (Dresden, Germany)

  • The Impact of Antipsychotic Dose Reduction Within a Medicare Population

    R. Ayyagari, F. Mu, A. Lax, B. Carroll (Boston, MA, USA)

  • The impact of anxiety on social functioning in Parkinson’s disease

    K. Perepezko, J. Hinkle, K. Mills, G. Pontone (Baltimore, MD, USA)

  • The impact of motor and non-motor symptoms on walking capacity in people with Parkinson’ disease

    H. Khalil, R. Rayhan, A. Al-Sharman, A. Aburub, K. El-Salem (Irbid, Jordan)

  • The Impact of the Sensory Trick on Gating Multimodal Afferents in Cervical Dystonia

    F. Brugger, J. Michelis, J. Walch, G. Kägi (St. Gallen, Switzerland)

  • « Previous Page
  • 1
  • …
  • 132
  • 133
  • 134
  • 135
  • 136
  • …
  • 149
  • Next Page »
Jump to:  [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • #25062 (not found)
    • Welcome to the MDS Abstracts Site
    • Effect of marijuana on Essential Tremor: A case report
    • Advanced Search
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley